Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use
NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients A...
Read More
Meeting Coverage
Neuroinflammatory Biomarkers: Linking HIV and Depression
The following is a summary of “(NEURO)INFLAMMATORY BIOMARKERS MEDIATE THE ASSOCIATION...
Read More
HIV Reservoir’s Impact on Natural Elite Control of HIV-1 Infection
The following is a summary of “IMPACT OF HIV RESERVOIR IN THE LOSS OF NATURAL ELITE CONTROL...
Read More
ASH Lymphoma eBook
Focus on ASH Lymphoma 2023v2.indd
Read More
The Impact of HIV on One-Year Mortality After ICU Admission
The following is a summary of “ONE-YEAR MORTALITY OF PEOPLE WITH HIV AFTER INTENSIVE CARE...
Read More
Estimation of HCC Risk in HIV/HBV Patients Using PAGE-B Score
The following is a summary of “PAGE-B SCORE TO ESTIMATE THE HEPATOCELLULAR CARCINOMA RISK IN...
Read More
Hepatic Resection Linked With Better OS After RT+TACE for HCC With MVI
In HCC with macroscopic vascular invasion, hepatic resection was significantly linked with better...
Read More
CROI 2023 COVID-19 Policy
Here are some highlights of CROI 2023 COVID-19 policy. To attend CROI 2023 in person attendees...
Read More
Looking Forward to CROI 2023 Opening Session
The opening session of CROI 2023 will be streamed live, with open access for all who are...
Read More
What You Don’t Want to Miss at CROI 2023
Key Sessions Welcome from the CROI 2023 Chair Sunday, Feb 19. 5:00-7:20pm Includes “CROI: A...
Read More
Highlights From CROI 2022
Research was presented virtually at CROI 2022, the annual Conference on Retroviruses and...
Read More
Novel Regimen May Avoid TME Surgery in Rectal Cancer
In patients with rectal cancer, neoadjuvant radiotherapy (RT) followed by atezolizumab and...
Read More
IMbrave 151 Missed Primary Endpoint in Advanced BTC
Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...
Read More
New Standard of Care for Colorectal Cancer
The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...
Read More
SWOG 1815, First-Ever Phase 3 Trial in BTC, Fails
The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...
Read More
Sorafenib Plus TACE May Control HCC After Resection
The postoperative adjuvant combination therapy of sorafenib plus transarterial chemoembolization...
Read More
Nanvuranlat Prolongs PFS in Refractory Advanced BTC
Patients with pre-treated, advanced biliary tract cancer (BTC) may benefit from treatment with...
Read More
New First-Line Option for Metastatic Pancreatic Duct Cancer
The phase 3 NAPOLI-3 trial showed that liposomal irinotecan plus 5-fluorouracil/leucovorin and...
Read More